Wyatt Investment Research login
 
Forgot password? Not a Subscriber? - Start Here
 
 
HOMEWEEKLY NEWSLETTERMODEL PORTFOLIOSPECIAL REPORTSVIDEO UPDATESCUSTOMER SERVICE
  
 

Tag - Vicr

 

  
Wyatt Research Staff

OncoGenex Pharmaceuticals, Colony Bankcorp and Isramco lead small-cap percentage losers

by Wyatt Research Staff, May 29, 2009
OncoGenex Pharmaceuticals Inc. (Nasdaq:OGXI), Colony Bankcorp Inc. (Nasdaq:CBAN) and Isramco Inc. (Nasdaq:ISRL) are among the biggest percentage losers in Friday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Mentor Graphics Corp. (Nasdaq:MENT), MAP Pharmaceuticals Inc. (Nasdaq:MAPP), Conn's Inc. (Nasdaq:CONN), NL Industries Inc. (Nasdaq:NL), Vicor Corp. (Nasdaq:VICR) and RXi Pharmaceuticals Corp. (Nasdaq:RXII).
[ More ยป ]
 

Research
Team

Ian Wyatt
Founder & CEO

Ian Wyatt founded Wyatt Investment Research in 2001 (formerly known as Business Financial Publishing), a publisher of investment newsletters and web sites for individual investors. With an audience that includes over 450,000 individual investors from around the world, the company is known to be a valuable source of unbiased investment opinions.